These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26233324)
1. Imaging predictors of remission to anti-depressant medications in major depressive disorder. Chi KF; Korgaonkar M; Grieve SM J Affect Disord; 2015 Nov; 186():134-44. PubMed ID: 26233324 [TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder. Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532 [TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder. Korgaonkar MS; Williams LM; Song YJ; Usherwood T; Grieve SM Br J Psychiatry; 2014 Oct; 205(4):321-8. PubMed ID: 24970773 [TBL] [Abstract][Full Text] [Related]
4. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427 [TBL] [Abstract][Full Text] [Related]
5. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression. Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948 [TBL] [Abstract][Full Text] [Related]
6. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. Rigucci S; Serafini G; Pompili M; Kotzalidis GD; Tatarelli R World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):165-80. PubMed ID: 19670087 [TBL] [Abstract][Full Text] [Related]
7. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the brainstem volume of patients with major depressive disorder and their relationship with antidepressant treatment. Han KM; Kim D; Sim Y; Kang J; Kim A; Won E; Tae WS; Ham BJ J Affect Disord; 2017 Jan; 208():68-75. PubMed ID: 27750062 [TBL] [Abstract][Full Text] [Related]
10. Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. Phillips JL; Batten LA; Aldosary F; Tremblay P; Blier P J Clin Psychiatry; 2012 May; 73(5):625-31. PubMed ID: 22394416 [TBL] [Abstract][Full Text] [Related]
11. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder. Fonseka TM; MacQueen GM; Kennedy SH J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145 [TBL] [Abstract][Full Text] [Related]
12. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes. Bouckaert F; Emsell L; Vansteelandt K; De Winter FL; Van den Stock J; Obbels J; Dols A; Stek M; Adamczuk K; Sunaert S; Van Laere K; Sienaert P; Vandenbulcke M J Affect Disord; 2019 May; 251():114-120. PubMed ID: 30921594 [TBL] [Abstract][Full Text] [Related]
13. White Matter Hyperintensity Accumulation During Treatment of Late-Life Depression. Khalaf A; Edelman K; Tudorascu D; Andreescu C; Reynolds CF; Aizenstein H Neuropsychopharmacology; 2015 Dec; 40(13):3027-35. PubMed ID: 26058663 [TBL] [Abstract][Full Text] [Related]
14. Impact of early and recent stress on white matter microstructure in major depressive disorder. Poletti S; Aggio V; Brioschi S; Bollettini I; Falini A; Colombo C; Benedetti F J Affect Disord; 2018 Jan; 225():289-297. PubMed ID: 28843078 [TBL] [Abstract][Full Text] [Related]
15. Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder. Katsuki A; Watanabe K; Nguyen L; Otsuka Y; Igata R; Ikenouchi A; Kakeda S; Korogi Y; Yoshimura R Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344826 [TBL] [Abstract][Full Text] [Related]
16. Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study. Vasic N; Wolf ND; Grön G; Sosic-Vasic Z; Connemann BJ; Sambataro F; von Strombeck A; Lang D; Otte S; Dudek M; Wolf RC J Psychiatry Neurosci; 2015 Nov; 40(6):412-21. PubMed ID: 26125119 [TBL] [Abstract][Full Text] [Related]
17. Cortico-limbic network abnormalities in individuals with current and past major depressive disorder. Klauser P; Fornito A; Lorenzetti V; Davey CG; Dwyer DB; Allen NB; Yücel M J Affect Disord; 2015 Mar; 173():45-52. PubMed ID: 25462395 [TBL] [Abstract][Full Text] [Related]
18. A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression. Phillips JL; Batten LA; Tremblay P; Aldosary F; Blier P Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25829180 [TBL] [Abstract][Full Text] [Related]
19. Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression. Disabato BM; Morris C; Hranilovich J; D'Angelo GM; Zhou G; Wu N; Doraiswamy PM; Sheline YI Am J Geriatr Psychiatry; 2014 Oct; 22(10):1039-46. PubMed ID: 23768683 [TBL] [Abstract][Full Text] [Related]
20. Structural connectivity and response to ketamine therapy in major depression: A preliminary study. Vasavada MM; Leaver AM; Espinoza RT; Joshi SH; Njau SN; Woods RP; Narr KL J Affect Disord; 2016 Jan; 190():836-841. PubMed ID: 26630613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]